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Abstract--The delayed cytotoxicity of 6-thioguanine (TG) may relate to the arrest of cells in G,_ upon 
completion of one cell cycle after drug exposure. In Chinese hamster ovary (CHO) cells, both the 
unilateral chromatid damage in G2 chromosomes, determined by induction of premature condensed 
chromosome condensation [Maybaum and Mandel, Cancer Res. 43, 3852 (1983)], and incorporation of 
TG into DNA resulting in DNA strand breakage [Christie et al., Cancer Res. 44, 3665 (1984)] were 
correlated with cytotoxicity. We have studied the correlation between strand breakage and unilateral 
chromatid damage in L1210 cells. DNA breaks were detected only when cells were treated with TG 
(0.25 gM) for one cell cycle time (12 hr) followed by 12 hr in drug-free medium containing [)H]thymidine 
(TdR) to label the DNA. After simultaneous incubation of cells with drug and label during the first or 
second 12-hr period, strand breaks were not found. Strand breaks increased with dose, which correlated 
with greater cytotoxicity (0.01 to 0.25/~M). Treatment of cells with 0.25/~M TG for 12 hr, and transfer 
to drug-free medium for 12 hr prior to making prematurely condensed chromosomes (PCC), resulted 
in unilateral chromatid damage. Prominent curving of G2 chromosomes with gapping and diffuse staining 
of one of the sister chromatids occurred. The 4-fold increase in the percentage of cells in G2 compared 
with control cells suggested G2 arrest. When cells were treated with TG for 12 hr and PCC made 
immediately, neither the arrest of cells in G2 nor unilateral chromatid damage was observed. These 
data suggest that strand breaks and unilateral chromatid damage occur in the second cell cycle after TG 
exposure and that this damage may be important in TG-delayed cytotoxicity. 
The antimetabolite, 6-thioguanine (TG), must be 
anabolized to thioguanylate to have activity as an 
antitumor agent [1]. TG, once activated, can alter 
cellular biochemistry at several sites. For example, 
TG depresses de n o v o  purine synthesis through inhi- 
bition of purine ring formation or purine inter- 
conversion [2-4]. These effects on purine metab- 
olism, however, have not always correlated with 
growth inhibition or cytotoxicity [5]. TG has also 
been found to replace guanine residues in both RNA 
and DNA [6, 7]. Although RNA synthesis may be a 
target for TG activity [8, 9], TG incorporation into 
DNA and the subsequent effects of its incorporation 
on DNA structure and function have been the focus 
of many investigations [7, 10-13]. TG is incorporated 
into DNA in a dose-dependent manner, and the 
extent of TG incorporation was correlated with cyto- 
toxicity [7]. Although TG incorporation into DNA 
is probably a key event in the production of cyto- 
toxicity, other events must occur before TG-induced 
toxicity is observed. Several investigators have found 
that mid to late S phase cells exposed to TG complete 
DNA synthesis and progress through G2 into mitosis 
]11, 14]'. After cell division, the drug-treated cells 
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continue through a second S phase and subsequently 
become arrested in G2. Thus, it appears that arrest 
in G2 is associated with the delayed lethality induced 
by TG [11]. 
Antitumor drugs which cause G 2 arrest have been 
shown to damage chromatin [15]. TG treatment has 
also been shown to alter chromatin structure [12, 16] 
and cause DNA strands breaks [7]. The damage to 
G 2 chromatids as visualized by premature chro- 
mosome condensation consisted of curving and kink- 
ing of Chinese hamster ovary (CHO) cell G2 prema- 
turely condensed chromosomes (PCC) and unilateral 
gaps and diffuse staining [12, 16]. The physical 
damage to the chromatin was dose dependent and 
correlated with the delayed cytotoxicity [12]. Cyto- 
toxicity has also been associated with TG incor- 
poration into DNA and subsequent production of 
single-strand breaks in CHO cells [7]. 
In the studies with L1210 cells reported here, DNA 
breakage, as detected by alkaline elution methods, 
and chromatin damage, as assessed by PCC analysis, 
have been correlated with drug-induced cytotoxicity. 
These studies suggest that the unilateral chromatid 
damage found after TG treatment may be a more 
general phenomenon and not restricted to a single 
cell type. Furthermore, these data support the 
hypothesis that TG-induced toxicity requires cell 
progression and a second period of DNA replication 
after the incorporation of the drug into the DNA. 
This second period of DNA synthesis results in 
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chromatin damage and DNA strand breakage which 
are correlated with cytotoxicity. 
M A T E R I A L S  AND M E T H O D S  
Drugs and chemicals'. TG was dissolved in double- 
distilled H20,  and the concentration was determined 
by measuring the absorption at 321 nm. 
[~H]Thymidine (TdR) (80 Ci/mmole) and [I4C]TdR 
(56 mCi/mmole)  were obtained from RPI (Mount 
Prospect, ILl and Moravek Biochemicals, Inc. 
(Brea, CA) respectively. Ultraviolet-irradiated Sen- 
dai virus was provided by Dr. Walter Hittelman, 
Department of Developmental Therapeutics, the 
University of Texas System Cancer Center, M.D. 
Anderson Hospital and Tumor Institute, Houston, 
TX. Colcemid, RPMI 1640, alpha-minimum essen- 
tial medium (MEM), dialyzed horse serum and calf 
serum were obtained from GIBCO Laboratories 
(Grand Island, NY). Fetal calf serum was obtained 
from Biofluids, Inc. (Rockville, MD). Unless other- 
wise noted, all other chemicals were obtained from 
standard chemical sources and were of the highest 
purity available. 
Cell culture. L1210 cells were maintained in con- 
tinuous suspension culture in RPMI 1640 medium 
supplemented with 10% dialyzed horse serum, peni- 
cillin G (105 units/l) and streptomycin (10(Img/1). 
Cells were passaged twice weekly, and a doubling 
time of 12 hr was found. CHO cells were grown in 
monolayer culture in alpha-MEM with 10% calf 
serum and 5% fetal calf serum. The doubling time 
for these cells was 12 hr. Both cell lines were main- 
tained in a humidified atmosphere of 95c4 air and 
5% CO2at  37 ° . 
Colony forming assays. The viability of L1210 cells 
after vehicle or drug treatment was assessed using 
the soft agar cloning method of Chu and Fischer [17]. 
Cells were treated with TG for 12 hr and washed 
twice, then diluted to a known cell number in 
RPMI 1640 supplemented with 20% dialyzed horse 
serum and agar (0.12%). For each drug concen- 
tration, a minimum of three different dilutions of 
cells were plated in triplicate and incubated for 10- 
12 days in a humidified atmosphere of 95% air-5Cf 
CO~ at 37 °. Colonies were counted and expressed 
as a percentage of control non-drug-treated cells. 
Control colony forming efficiencies were typically 
between 80 and 90%. 
Premature chromosome condensation. Visualiz- 
ation of unilateral chromatid damage and dis- 
turbances of cell cycle progression were assessed by 
premature chromosome condensation as described 
by Hittelman and Rao [18]. L1210 cells were exposed 
to TG for 12 hr. The drug was removed and the 
cells were resuspended in drug-free medium for an 
additional 12 hr, after which time PCC were made. 
Another group of cells was exposed to TG for 12 hr 
and PCC were made immediately. Control cells 
received no drug treatment. Three million control 
or TG-treated El210 cells were combined with one 
million mitotic CHO cells in 5 mM piperazine-N-N'- 
bis(2-ethanesulfonic acid) (PIPES) buffer at pH 7.4 
and mixed thoroughly. Mitotic CHO cells were pre- 
pared by mitotic detachment of cells that had been 
treated with {I.05 !lg/ml colcemid for 3 hr. 
The L1210/mitotic CHO cell mixture was centri- 
fuged and resuspended in 0.5 ml of Hanks' balanced 
salt solution (HBSS; GIBCO, Grand Island, NY) 
containing approximately 4000 hemagglutinating 
units of Sendi virus per ml of HBSS and then placed 
in an ice water bath at 4 ° for 15 min. The virus-cell 
fusion mixture was transferred to a 37 ° water bath 
for 45 min after the addition of 50 I*1 of an HBSS 
solution containing 100 mM MgCI: and 4 !lg//ml col- 
cemid. The cells were swollen hypotonically bv the 
addition of 7 ml of 0.075 M KCI and incubated at 
room temperature for 12 min. Cells were collected 
by centrifugation, fixed with methanol/glacial acetic 
acid (3 : 1), and then dropped onto clean, wet micro- 
scope slides. The air-dried slides were stained with 
2% aceto-orcein (GIBCO), The slides were coded 
and then scored blindly using a light microscope. 
The spreads were located at 400x and then examined 
at 1000x to determine the PCC morphology. At 
least 100 PCC spreads were scored for each treat- 
ment group. 
Alkaline elution assay for single-strand breaks. 
Alkaline elution methods were used to assess DNA 
strand breaks according to the method described 
by Kohn et al. [19]. LI210 cells were labeled with 
[3H]TdR (0.1 l~Ci/ml, 1/~M) and treated with TG in 
one of four ways, as illustrated in Fig. 1, before 
analysis by alkaline elution methods. One group of 
cells (I) was simultaneously treated with [3H]TdR 
and 0.25 ,aM TG for 12 hr and then incubated for an 
additional 12 hr in fresh medium. Group II cells were 
treated in a similar fashion, except that alkaline 
elution analysis for single-strand breakage was per- 
formed immediately after TG exposure for 12 hr. A 
third group of cells (III) was prelabeled with 
[3H]TdR for 12 hr. After labeling, the medium was 
removed and new medium containing 0.25 llM TG 
was added for 12 hr. Group IV cells were exposed 
to 0.25 uM TG for 12 hr. After drug exposure, the 
medium was removed and replaced with drug-free 
medium containing [~H]TdR. Group IV cells were 
incubated for an additional 12 hr prior to analysis of 
DNA single-strand breaks bv alkaline elution 
methods. 
Control cells were labeled with [3H]TdR or 
[~aC]TdR (0.01 !~Ci/ml, 1 !lM) for 12 hr. Control ~tt- 
labeled cells received either 0 or 300rads of X- 
irradiation on ice just prior to alkaline elution analy- 
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Fig. 1. Schedule of drug treatment and labeling used in 
alkaline elution experiments. Closed bars represent 12-hr 
exposure to TG-containing medium, open bars indicate 12- 
hr incubation in drug-free medmm, asterisks indicate the 
presencc of I~H]TdR, and arrows indicate the time at which 
cells ~cre harvested for elution analysis. 
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received 300 rads of X-irradiation on ice just prior 
to alkaline elution analysis. All cells were kept at 4 ° 
in the dark until analyzed. Aliquots of experimental 
(3H-labeled) cells and the internal standard (I~C- 
labeled) cells were mixed and applied to 2 #m poly- 
carbonate filters (Nucleopore Corp., Pleasanton, 
CA). The cells were then lysed using a lysis buffer 
containing 5% sodium dodecyl sulfate, 20mM 
EDTA and 100 mM glycine at pH 10. This solution 
was drained by gravity, and 2 ml of the lysis solution 
containing proteinase K (0.5 mg/ml) was pumped 
through the filter at the rate of 2 ml/hr to remove 
protein associated with the DNA. The DNA was 
eluted with 40 mt of solution containing 0.1 M tetra- 
propyl ammonium hydroxide, 20 mM EDTA, and 
0.1% sodium dodecyl sulfate, pH 12.1, at a rate of 
2 ml/hr. Fractions were collected directly into mini- 
scintillation vials at 90-min intervals for 15 hr. Liqui- 
scint (National Diagnostics, Somerville, N J) count- 
ing solution containing 0.7% glacial acetic acid was 
added, and the fractions were counted on a Beckman 
LS 6800 liquid scintillation counter. The filters were 
collected, and the residual DNA was hydrolyzed 
with 0.4 ml of 1 N HC1 for 1 hr at 90 ° to determine 
the amount of radioactivity remaining on the filter. 
Scintillation counting was carried out as described 
above. To remove any residual radioactivity from 
the pump tubing or system, 2 ml of 1 N NaOH was 
flushed through the system, collected as a single 
fraction, and counted. 
To determine the total [3H] and [14C] contained 
in a sample, the amounts in the individual fractions 
were summed along with that contained in the lysis 
solution, the NaOH fraction, and the fl ter fraction. 
The fraction of [3H] (experimental cells) remaining 
on the filter was plotted against the fraction of [14C] 
(internal standard cells) remaining on the filter. 
RESULTS 
Cytotoxicity studies. L1210 cells exposed to 
Increasing concentrations of TG for 12 hr showed a 
dose-related decrease in survival as assessed by col- 
ony formation in soft agar (Fig. 2). The threshold for 
toxicity was 0.01 gM. At a concentration of 0.25 ~M 
TG, a 2log cell kill was found. Morphologic and 
biochemical analyses of TG-induced damage were 
conducted in cells exposed to 0.25/~M drug. 
Cell cycle position classified by PCC morphology. 
L1210 cells were treated with TG or vehicle and fused 
with mitotic CHO cells to make PCC as described in 
Materials and Methods. PCC spreads were scored as 
to their position in the cell cycle, based on chromatin 
morphology. The classification scheme relies on the 
observation that, as cells progress from G1 into S, 
the chromatin decondenses in preparation for DNA 
synthesis in a characteristic manner [18]. Decon- 
densation is manifested in two ways. First, chromatin 
structures elongate. Second, discontinuities are 
observed as apparent breaks or gaps in the chroma- 
tin. These discontinuities are not frank breaks in 
DNA structure, but represent areas in which DNA 
has become unwound to such an extent that it is no 
longer visible under the light microscope. As cells 
progress from S into G2, bifilial PCC are apparent 
[18, 20]. 
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Fig. 2. L1210 cell survival after 12-hr exposure to TG. 
L1210 cells in logarithmic growth were exposed to TG 
(0.0025 to 0.25 ~M) for 12 hr and then prepared for colony 
forming assays as described in Materials and Methods. 
Data are expressed as a percentage of untreated control 
cells. Each point represents the mean _+ S.E. for at least 
three determinations• 
The classification scheme consisted of four PCC 
groups in addition to the distinct bifilial G 2 PCC. 
Group 1 consists of PCC that are highly to mod- 
erately condensed single chromatid structures with 
few or no discontinuities and which arise from cells 
in early to mid G I (see Fig. 3). In group 2 spreads, 
the chromatin is more extended than in group 1 and 
some areas of discontinuity are found. The chromatin 
is mostly discontinuous in group 3, although some 
regions of extended chromatin still exist. Spreads 
classed as 2 and 3 arise from cells that are in late G1 
or early S. In group 4, the chromatin is maximally 
decondensed and completely discontinuous in 
appearance and arises from cells in S phase. PCC 
spreads which were completely or nearly completely 
bifilial were classified as G2. Spreads having this 
morphology come from cells that have finished rep- 
lication and have initiated recondensation in pre- 
paration for mitosis [20]. These classifications are 
based upon the classical descriptions reported by 
Rao and Johnson [20] and further discussed by Rao 
et al. [21]. Although no other methods were used in 
the present study to correlate PCC morphology and 
cell cycle position, prior work in this field has demon- 
strated the usefulness of this technique in assessing 
cell cycle position after drug treatment [12, 18, 20]. 
Classification of unilateral chromatid damage in 
vehicle or drug-treated cells. The distinctly bifilial G 2 
PCC spreads were further classified as to the degree 
of unilateral chromatid damage. This unique type of 
damage to chromatid structures after exposure to 
TG was described originally in G: PCC of CHO cells 
[16]. This form of chromosomal disruption is distinct 
from the usual gaps, breaks and exchanges often 
observed with other DNA damaging agents [22, 23]. 
Unilateral chromatid damage was observed as curl- 
ing and kinking of G~ PCC. In addition, numerous 
regions which were diffusely stained or gapped were 
found in the kinked and curled chromatid. The sister 
chromatid, however, showed no evidence of damage. 
In the studies reported here in L1210 cells, we also 
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Fig. 3. Photomicrographs of PCC decondensation groups of L L2 l() ceils. The spreads pictured here arc 
representative of the degree of chromatm decondcnsation, which ~as the criterion used to assign a PC(' 
spread to either group 1, 2. 3, or 4. The characteristics of each group arc discussed in Results, "'M" 
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found unilateral chromatid damage in Gx cells. This 
damage was classified according to the degree of 
deformation observed and assigned to one of three 
categories,  G2-+0,  G 2 - + l ,  or G2-+2 (Fig. 4). 
Spreads that contained less than three kinks were 
assigned a deformat ion score of G2-+0.  In this scor- 
ing system, a "kink" was defined as a bend in the G :  
chromatid of at least 90 ° which occurred over  a 
distance of not more  than twice the width of the 
PCC. A curved region of the chromatid that included 
the cent romere  was not classed as a kink. To be 
assigned a G2-+ l  deformat ion score, a spread had 
to contain PCC with at least three kinks, but no 
differential chromatid staining. When at least three 
kinks and regions of differential chromatid con- 
taining were present,  the spread was assigned a 
deformation score of G2-+2.  If it was unclear as to 
which class a particular spread should be assigned, 
the lower of the two classifications was used. All 
slides were coded before the slides were scored for 
unilateral chromatid damage by an independent  
observer.  Af ter  evaluation,  the codes were broken 
and the accumulated data were assessed. In no man- 
ner does the scoring system used to classify the 
unilateral chromatid damage found in G2 PCC imply 
any progression through the G2 phase of the cell 
cycle. 
Analysis of TG-treated cells by PCC decon- 
densation morphology. To analyze cell cycle position 
after TG t reatment ,  the decondensat ion morpho-  
logies of PCC were classified. Figure 5 shows PCC 
decondensat ion histograms for three types of drug 
treatment:  vehicle-treated control cells ( t reatment  
A),  cells treated with T G  (0.25/~M) for 12 hr and 
then analyzed by premature  chromosome con- 
densation ( t reatment  B), or cells t reated with TG 
(0.25/JM) for 12 hr followed by an additional 12 hr 
in drug-free medium with subsequent  PCC analysis 
( t reatment  C). Trea tment  A shows a typical distri- 
bution of PCC spreads for vehicle- treated control 
cells. As described above (Fig. 3), an increase in 
the numerical  value of the decondensat ion score 
represents progression through the cell cycle from 
G1 into S, with group 4 represent ing S-like PCC. For  
vehicle-treated cells, 80% of the total spreads scored 
were found in groups 2, 3 or 4. G2 spreads made up 
15% of the total number  scored. With t rea tment  
B (12-hr TG treatment  and then immedia te  PCC 
analysis), the distribution of spreads was similar to 
that observed in control cells. Al though about half 
as many group 3 spreads were found in t reatment  B 
compared to t rea tment  A,  approximately 80c/c of the 
spreads were classified as belonging in groups 2-4 
and spreads in G2 made up about 15%: of the scored 
spreads. In contrast,  t rea tment  C (12-hr TG 
exposure,  followed by 12 hr in TG-f ree  medium,  
then PCC analysis) produced a PCC distribution 
that was very different from A or B. Gz spreads 
constituted 67%. of the total spreads scored with a 
corresponding decrease in the number  of spreads in 
groups 1 through 4 compared  with control. The 
group 4 spreads represent  those cells in S phase. The 
percent  of total spreads classified as in group 4 were 
equivalent  for t reatments  A and B (22%). In 
contrast,  for t rea tment  C, 8% of the total spreads 
were classified as group 4 spreads. 
' :1 B a} 
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Fig. 5. Frequency distributions of PCC decondensation 
morphologies according to TG treatment schedule. Data 
are: treatment A, control cells; treatment B, exposure to 
TG (0.25 ~M) for 12 hr followed by PCC analysis: treatment 
C, same as B, but incubated for an additional 12 hr in drug- 
free medium before PCC analysis. The results are expressed 
as a percentage of the total PCC spreads scored in each 
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Fig. 6. Extent of G~ PCC damage according to TG treat- 
ment schedule. Treatments A, B, and C were carried out 
as described in Fig. 5. The results are expressed as a 
percentage of the total number of G., PCC spreads scored 
for each treatment group; 30-65 G: PCC spreads were 
examined for each group. 
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Analysis of unilateral chromatid damage induced 
by TG. In addition, G2 spreads were further classified 
as to the extent of unilateral chromatid damage 
observed, as described above, and shown in Fig. 3. 
Ninety percent of the G,  PCC spreads from control 
cells appeared normal with virtually no kinking and 
were assigned a deformation score of +0 (treatment 
A in Fig. 6). A baseline level of moderate chromatid 
deformation (+ 1) was observed in 10% of the control 
Gz spreads. Treatment B did not alter the distri- 
bution of unilateral chromatid damage in the G2 
PCC. Treatment C, however, produced a major shift 
in the percentage of spreads with a higher deform- 
ation score. Nearly 80% of the G2 spreads scored 
had moderate to major unilateral chromatid damage 
with approximately equal numbers of G2 spreads in 
each category (+ 1 or +2 deformation scores). Only 
20% of the G2 spreads analyzed in treatment C were 
1.0 A 
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Fig. 7. DNA single-strand break production in L1210 cells 
according to TG schedule (A) and dose (B). Panel A, 
treatment schedules (see Fig. 1) were: I (A) simultaneous 
3H-labeling and TG exposure for 12 hr followed by 12 hr in 
fresh medium; II (0) simultaneous 3H-labeling and TG 
exposure for 12 hr; III (V) 3H-prelabel for 12 hr followed 
by 12-hr TG exposure without label; IV (m) TG exposure 
for 12 hr followed by 12 hr 3H-label. All TG treatments 
were with 0.25 ttM drug. In Panel B, L1210 cells were 
treated with different doses of TG according to schedule 
IV. TG doses were: 0.01/~M (A), 0.025/~M (V), and 
0.25/~M ( i ) .  In both panels (O) represents control cells 
without treatment and (O) represents cells which received 
300 rads of X-iradiation before alkaline elution. In all cases, 
]4C-labeled cells were given 300 rads of X-irradiation prior 
to alkaline elution. 
found to exhibit normal G 2 PCC morphology (+0 
deformation score) with respect to kinking or dif- 
ferential chromatid staining. 
Assessment of TG-induced strand breaks by alka- 
line elution. Alkaline elution was used to determine 
the ability of TG to cause breaks in the DNA of 
El210 cells. Strand breaks were monitored after four 
different schedules of TdR labeling of DNA and TG 
treatment as described in Materials and Methods and 
illustrated in Fig. 1. Figure 7A shows that group IV 
produced the most rapid rate of elution, indicating 
that this labeling and treatment schedule produced 
DNA strand breaks. The single-strand break fre- 
quency in rad-equivalents for the experiment in Fig. 
7A was 113. Cells treated according to schedules I, 
II, or III eluted from the filters at rates similar to 
that observed in non-drug-treated cells. 
Because it appeared that TG treatment followed 
by 12 hr post drug exposure labeling was the only 
schedule to result in strand breaks, a series of studies 
using this protocol was carried out to see if the strand 
break production was dose related. The results are 
shown in Fig. 7B. TG concentrations of 0.01, 0.025 
and 0.25 gM gave increasing amounts of strand break 
production, in which the single-strand break fre- 
quencies in rad-equivalents for the experiment 
shown in Fig. 7B were 34, 51, or 101 respectively. 
DISCUSSION 
Both unilateral chromatid damage [12, 16] and 
DNA strand breakage [7, 13] have been proposed as 
mechanisms for cytotoxicity induced by TG. Other 
investigations have suggested that TG toxicity is 
delayed [11, 12, 14, 16] with the appearance of chro- 
matid damage in the cell cycle following TG incor- 
poration [11, 12, 16]. Correlation of DNA strand 
breakage and/or chromatid damage with cytotoxicity 
has been difficult due to the use of different cell 
lines. The focus of this study was to correlate the 
production of unilateral chromatid damage and 
DNA strand breakage by TG in L1210 cells, which 
are sensitive to TG-induced toxicity. In addition, the 
studies reported here extend previous investigations 
which attempted to explain the mechanisms for 
delayed cytotoxicity of TG. L1210 cells incubated 
with 0.01 to 0.25 gM TG for 12 hr showed a dose- 
related increase in cytotoxicity. At the lower dose 
(0.002 #M), no apparent cytotoxicity was found. The 
concentration of TG required to produce a 50% 
reduction in survival after a 12-hr exposure was 
estimated to be 0.02 ktM. Increasing the exposure 
time for TG to 16 hr lowered the Los0 to 0.008/~M 
(data not shown). In CHO cells exposed to TG 
for 16 hr, 0.5 #M drug produces a 50% decrease in 
survival [12]. When a CHO cell subline, AA8, which 
was competent in DNA repair was studied, the 
reported Lcs0 was approximately 1 ~M after 24 hr of 
exposure [7]. These results suggest that L1210 cells 
are 25- to 125-fold more sensitive to TG than CHO 
cells. 
Because L1210 cells are more sensitive to TG, 
unilateral chromatid damage and DNA damage 
should occur at lower concentrations of TG, if these 
manifestations of nuclear disruption play an impor- 
tant role in TG lethality. Maybaum and Mandel 
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[12, 16] demonstrated chromatid disruption in CHO 
cells after the cells were exposed to TG. Two forms 
of chromatid disruption were observed by these 
investigators. At  lower doses, 80% of the G2 PCC 
spreads exhibited prominent kinking [12, 16]. At  a 
higher dose (4/aM), unilateral chromatid damage in 
the form of diffuse staining and gapping occurred in 
20% of the G2 PCC spreads in addition to prominent 
kinking (80% of total G~ spreads) [12, 16]. Fur- 
thermore, kinking was always observed in spreads 
which exhibited unilateral chromatid damage 
[12, 16]. In the studies reported here, L1210 cells 
treated with 0.25 gM TG exhibited extensive 
chromatin damage. Unilateral chromatid damage 
was found in 40% of the G~ PCC spreads (Fig. 6). 
The damage observed in L1210 cells (Fig. 6) was very 
similar to that seen in CHO cells [12, 16]: kinking in 
moderately damaged chromatin, while more severe 
disruption was manifest as kinking and unilateral 
chromatid damage, These data suggest that TG- 
induced toxicity is associated with the presence of 
unilateral chromatid damage and/or  kinking in cell 
lines sensitive to TG. Furthermore,  the unilateral 
chromatid damage induced by TG is not unique to 
CHO cells but may be a general feature of delayed 
TG toxicity. 
TG is known to incorporate into DNA,  but this 
incorporation does not affect DNA synthesis 
immediately because TG-treated cells are able to 
complete S phase and divide [11, 14]. It is only after 
a second round of DNA synthesis that cell pro- 
gression is disrupted, and the cells become arrested 
in G2 [11]. The irreversible arrest in G2 of TG- 
treated cells has been associated with a primary event 
leading to cell death. Data presented here and by 
Maybaum and Mandel [12, 16] suggest that the Gz 
arrest of TG-treated cells may result from the dis- 
ruption of chromatin structure which was manifested 
in these studies by kinking and unilateral chromatid 
damage. When El210 cells were exposed to 0.25/~M 
TG for 12 hr and then PCC were made immediately 
(treatment B), no disruption of G~ PCC was seen 
(Fig. 6), nor was there arrest of cells in G2 (Fig. 
5). When the cells were treated with TG for 12 hr 
followed by a 12-hr period in drug-free medium 
(treatment C), cells were arrested in G:  (Fig. 5) and 
chromatin disruption was observed in G2 PCC (Fig. 
6). The doubling time for the L1210 cells employed 
in the present report was 12 hr. Taken together the 
data suggest that at least two rounds of DNA syn- 
thesis must occur in order for TG-induced arrest in 
G2 and chromatin damage to be manifested in El210 
cells. In the present studies, the schedule which 
produced both G2 arrest and chromatin damage was 
treatment C. Treatment C permitted TG to be incor- 
porated into DNA during the first 12hr of 
incubation, corresponding to one doubling time for 
L1210 cells. Other investigators have demonstrated 
that the incorporation of 2'-deoxy-6-thioguanosine- 
5'-triphosphate into DNA proceeds efficiently when 
normal DNA is used as a template [24]. This first 
round of replication in L1210 cells would lead to the 
presence of TG in one strand of the DNA. After 
12hr in drug-containing medium, the cells were 
washed and placed in fresh medium for an additional 
12 hr to permit a second round of DNA synthesis in 
the absence of TG. It is possible that. during this 
second round of DNA synthesis, the TG-containing 
DNA strand acts as a faulty template and results in 
the production of kinked and/or  unilaterally dam- 
aged chromatids. It is not known whether TG-con- 
taining DNA can be replicated in the normal manner. 
It has been shown, however, that the transcription 
of synthetic DNA substituted with TG is inhibited 
[251. 
Chromatin damage induced by TG appears to 
occur in the newly synthesized DNA that does not 
necessarily contain TG, but which is replicated from 
the TG-containing DNA strand, This is demon- 
strated by the appearance of strand breaks only 
when DNA is labeled during the second round of 
replication after TG treatment (Fig. 7A, group IV). 
This would suggest that TG is incorporated into 
DNA in a normal fashion, but the TG-containing 
template causes the subsequent synthesis of damaged 
DNA leading to the appearance of unilateral chro- 
matid damage. Other investigators [7,13], in 
contrast, have reported the presence of DNA strand 
breaks occurring early after TG treatment, sug- 
gesting that the damage could occur in the parental 
strand at high drug doses. It is possible that this 
discrepancy is due to different drug doses employed 
in the various studies. 
Maybaum and Mandel [12] suggest that chromatm 
disruption which occurs in TG-treated CHO cells 
represents a change in chromosome structure or 
composition. Furthermore,  they suggest that the dis- 
tortion observed may be due to either breaks in the 
DNA occurring in the affected region or the failure 
of the chromatin to condense properly [ 121. The data 
presented here support the former hypothesis. DNA 
strand breaks, as measured by alkaline elution 
methods, were observed only when [~H]TdR ~as 
incubated for 12hr with cells that had been pre- 
treated with TG. Coincubation of TG and [3HVIdR 
during the initial 12-hr period produced no dis- 
cernible DNA strand breaks. These data suggest that 
TG incorporation into DNA alone does not produce 
measurable strand breaks. It is only when [3It]TdR 
labeling occurs of cells whose DNA is already sub- 
stituted with TG that the strand breaks are apparent. 
Other investigators have found DNA strand breaks 
in TG-treated cells but did not report the time sched- 
ule dependence for effects of drug and TdR labeling 
schedules in their studies [7]. The appearance ~f 
DNA strand breakage and unilateral chromatid 
damage during the same time sequence suggests that 
these two manifestations of TG-induced damage may 
play a critical role in TG lethality. Further work will 
be required to determine if the correlations among 
DNA damage, DNA strand breakage and cvto- 
toxicity that we have observed are merely the result 
of drug treatment or the cause of cell death per se. 
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